Total Funding
82
78
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3909
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
- Wesley Kaupinen: Founder and CEOPast Role: Insmed, Senior Vice President of Corporate Development and Commercialization
- Wesley Kaupinen: PresidentPast Role: Insmed, Senior Vice President of Corporate Development and Commercialization
About the Company
Palvella Therapeutics is a start-up life sciences company that focuses on relentlessly and selflessly serving abandoned patient populations with therapies. The company specializes in developing therapies that specifically target the root cause of the disease.
Palvella Therapeutics was founded in 2015 and headquartered in Wayne, Pennsylvania.
